Concentric Capital Strategies, LP Leap Therapeutics, Inc. Transaction History
Concentric Capital Strategies, LP
- $2.38 Billion
- Q3 2024
Shares
2 transactions
Others Institutions Holding LPTX
# of Institutions
1Shares Held
265KCall Options Held
0Put Options Held
0About LEAP THERAPEUTICS, INC.
- Ticker LPTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 99,021,400
- Market Cap $292M
- Description
- Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which is in multiple ongoing clinical trials for treating esophagogastric, hepatobiliary, gynecologic, and prostate can...